English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduAmong transgender and gender-diverse adults whose gender identity is nonbinary—not exclusively male or female—and who choose low-dose hormone treatment, most prefer to continue testosterone therapy at lower-than-recommended doses after at least six months of treatment, a new study finds. The study will be presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Tag: gender-affirming care
Cedars-Sinai Experts Available for Interviews at American Urological Association Annual Meeting May 3-6
Physician-scientists from the Department of Urology at Cedars-Sinai will be attending the American Urological Association (AUA) Annual Meeting May 3-6 in San Antonio, Texas, and are available to discuss the latest research and innovations in urological care.
Pediatric endocrinologists concerned for safety amid divisive political climate
Pediatric endocrinologists are concerned for their safety and their ability to provide evidenced-based care to transgender and gender-diverse adolescents amid political divides over gender-affirming care, according to a new paper published in the Journal of the Endocrine Society.
Mapping the changing landscape of gender-affirming care for teens
Many families whose transgender children need gender-affirming care will need to drive much further than before because of laws and other actions passed since 2021 in 20 states, a new study shows. Half will need to drive an hour or more; 25% four hours each way.
Endocrine Society’s new Scientific Statement identifies research gaps in pediatric, LGBTQIA care
In a new Scientific Statement released today, the Endocrine Society identifies areas for future endocrine research to reduce health disparities in pediatric and sexual and gender minoritized populations.
Endocrine Society celebrates UK Court of Appeal decision to preserve access to gender-affirming care
The Endocrine Society applauded the Court of Appeal’s ruling that transgender and gender diverse teenagers are competent to give consent to treatment to delay puberty.